| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 01/03/2007 | EP1509301B1 Production of crystalline materials by using high intensity ultrasound |
| 01/03/2007 | EP1133518B1 A method for the preparation of n-neohexyl-(a)-aspartyl-l-phenylalanine methyl ester from imidazolidin-4-one intermediates |
| 01/03/2007 | CN1890259A Method for the synthesis of derivatives of (2S,3AS,7AS)-1-[(S)-alanyl]-octahydro-1H-indole-2-carboxylic acid and use thereof for the synthesis of perindopril |
| 01/03/2007 | CN1890258A Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 01/03/2007 | CN1890215A Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 01/03/2007 | CN1890210A Alpha-ketoamide derivative, and production method and use thereof |
| 01/02/2007 | US7157485 2S, 3aS, 7aS)-1-{(2S)-2 [(tert-Butoxycarbonyl)-amino]-propionyl}-octahydro-1H-indole-2-carboxylic acid; using, as sole sources of chirality, alanine starting material and a compound readily accessible from serine |
| 01/02/2007 | US7157433 Compounds, compositions as carriers for steroid/nonsteroid anti-inflammatory; antienoplastic and antiviral active molecules |
| 01/02/2007 | US7157430 (Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases |
| 01/02/2007 | US7157420 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 01/02/2007 | US7157419 Growth factor binding molecules |
| 01/02/2007 | US7157275 growing adherent cells using a cell adhesion promoting ("CAP") peptide covalently coupled to a cell adhesion resistant layer such as hyaluronic acid on a polystyrene surface to promote cell attachment, growth differentiation, in culture; biological scaffolds |
| 01/02/2007 | US7157250 Glutamic acid receptor and utilization thereof |
| 01/02/2007 | CA2274464C Ketobenzamides as calpain inhibitors |
| 12/28/2006 | WO2006138721A1 Anti-gfralpha3 antibodies |
| 12/28/2006 | WO2006137075A1 Compositions and methods for preventing or treating hiv infection |
| 12/28/2006 | WO2006023452A3 Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases |
| 12/28/2006 | WO2004041067A3 Prevention and treatment of synucleinopathic disease |
| 12/28/2006 | US20060293372 Beta-sheet mimetics and methods relating to the use thereof |
| 12/28/2006 | US20060293247 Peptide derivatives; thyrotropin-releasing hormone-degrading; brain and spinal injuries, central nervous system disorders |
| 12/28/2006 | US20060293224 Conformationally stabilized cell adhesion peptides |
| 12/28/2006 | US20060292657 Phex substrates and methods using same |
| 12/28/2006 | DE10356409B4 Neues Arzneimittel Oxachelin und Derivate New drug Oxachelin and derivatives |
| 12/28/2006 | CA2612417A1 Anti-gfralpha3 antibodies |
| 12/28/2006 | CA2583345A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
| 12/27/2006 | EP1736540A1 Process for producing dipeptides |
| 12/27/2006 | EP1735345A2 Processes for preparing eptifibatide and pertinent intermediate compounds |
| 12/27/2006 | EP1735336A2 Omi pdz modulators |
| 12/27/2006 | EP1735055A1 Method of reducing c-reactive protein using growth hormone secretagogues |
| 12/27/2006 | EP1480961B1 Glutaminyl based dpiv inhibitors |
| 12/27/2006 | EP1427423B1 Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| 12/27/2006 | EP1404704B1 Bridged bicyclic serine protease inhibitors |
| 12/27/2006 | EP1379515B1 Lipid lowering biphenylcarboxamides |
| 12/27/2006 | EP1187806B1 Spermine:peptide-based surfactant compounds |
| 12/27/2006 | EP1103560B1 Novel thiazolidine derivatives |
| 12/27/2006 | CN1886422A A method of modulating cell survival, differentiation and/or synaptic plasticity |
| 12/27/2006 | CN1886421A Hemiasterlin derivatives and uses thereof |
| 12/27/2006 | CN1884516A Design and fermented production of recombinant peptide for reducing blood pressure |
| 12/26/2006 | US7153864 Polyglutamic acid-camptothecin conjugates and methods of preparation |
| 12/26/2006 | US7153835 Dipeptides and tripeptides for treating inflammatory reactions, including allergic reactions |
| 12/21/2006 | WO2005062967A3 Novel anti-il 13 antibodies and uses thereof |
| 12/21/2006 | WO2004096153A3 Prostate cancer therapeutics and diagnostics based on conformers of prostatic acid phosphatase |
| 12/21/2006 | US20060287504 Universal procedure for refolding recombinant proteins |
| 12/21/2006 | US20060287402 Cathepsin inhibitors |
| 12/21/2006 | US20060287306 Compounds to treat alzheimer's disease |
| 12/21/2006 | US20060287280 N-[1-Carboxy-2-(1H-indol-3-yl)-ethyl]-3-(2-mercapto-acetylamino)-succinamic acid; zinc metallopeptidase inhibitors; promoting faster regeneration of bone mass after bone fractures, implantation of orthopedic and dental prostheses; osteogenesis stimulant; control phosphate metabolism |
| 12/21/2006 | US20060287252 Substances k01-0509 and process for producing the same |
| 12/21/2006 | US20060287250 Intermediates: omega(1-haloalkoxycarbonylamino)alkanoates, e.g., Benzyl 1-{[(1-Chloroethoxy)carbonyl]aminomethyl}-1-Cyclohexane Acetate |
| 12/21/2006 | US20060287249 Of EtO2C CH2 (R)Cgl-Aze-Pab-OH or its salt; high chemical and solid state stability; thrombin inhibitors |
| 12/21/2006 | US20060287247 Halogen-substituted thienyl compounds |
| 12/21/2006 | US20060287239 Biologically active peptides |
| 12/20/2006 | EP1733231A2 Peptides and peptidomimetics binding to cd23 |
| 12/20/2006 | EP1732596A2 Therapeutic use of rm1 antigen |
| 12/20/2006 | EP1194164B1 Prion protein peptides and uses thereof |
| 12/20/2006 | CN1882683A Microbe capable of producing dipeptide and process for producing dipeptide with the microbe |
| 12/20/2006 | CN1882607A Method for synthesis of perindopril and its pharmaceutically acceptable salts |
| 12/20/2006 | CN1290858C Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof |
| 12/19/2006 | US7150869 Gene therapy; cytokine complex; anticancer agent |
| 12/14/2006 | WO2006133147A2 Organic compounds |
| 12/14/2006 | WO2006131586A1 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same |
| 12/14/2006 | WO2006087550A8 Amyloid-binding peptides, analogues and uses thereof |
| 12/14/2006 | WO2006074409A9 Tripeptide and tetrapeptide sulfones |
| 12/14/2006 | US20060281732 4-[(3-aminopropyl) (ethyl)amino]-2-{[1-(carboxymethyl)-2-oxo-2, 3, 4, 5-tetrahydro-1H-1benzazepin-3-yl]amino}carbonyl)-cyclopentyl]methyl}-4-oxobutanoic acid; neutral endopeptidase or human soluble endopeptidase (hSEP) inhibitors; cardiovascular diseases, apoptosis, stroke, neurodegenerative disorder |
| 12/14/2006 | US20060281686 Aza-peptides |
| 12/14/2006 | US20060280784 amphiphilic substance or a hydrophobic substance is modified with a glycerol derivative, which is useful as a surface modifier for producing a drug carrier; liposome, a fat emulsion, an emulsion, a micell and a fine particle crystal |
| 12/14/2006 | CA2611416A1 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method for the production thereof |
| 12/14/2006 | CA2610396A1 Organic compounds |
| 12/13/2006 | EP1730313A1 Protein expression yield enhancement in cell-free protein synthesis systems by addition of antifoam agents |
| 12/13/2006 | EP1730168A2 Functional method for generating or screening for ligands which modulate steroid hormone receptors |
| 12/13/2006 | EP1730167A1 Macrocyclic peptides active against the hepatitis c virus |
| 12/13/2006 | EP1730166A2 Process for preparing macrocyclic dipeptides which are suitable for the treatment of hepatitis c viral infections |
| 12/13/2006 | EP1730165A1 Inhibitors of hepatitis c virus ns3 protease |
| 12/13/2006 | EP1730142A1 Novel ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus |
| 12/13/2006 | EP1730110A1 Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 12/13/2006 | EP1729757A2 Inhibitors of dipeptidylpeptidase iv for regulating glucose metabolism |
| 12/13/2006 | EP1551441B1 Peptides and recombinant proteins mimicking interferons |
| 12/13/2006 | EP1478382B1 Method for producing a powder inhalant containing a salt of the cgrp antagonist bibn4096 |
| 12/13/2006 | EP1091930B1 C-TERMINAL MODIFIED OXAMYL DIPEPTIDES AS INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 12/13/2006 | CN1879051A Translating bifocal wear modality |
| 12/13/2006 | CN1878788A Substances K01-0509 and process for producing the same |
| 12/12/2006 | US7148378 Analgesics; neuropathic pain; bipolar disorders |
| 12/12/2006 | US7148347 Reacting macrocyclic amide compound with hydroxy naphthalene or hydroxy quinoline derivative in a polar non-protic organic solvent in the presence of an organic or inorganic base |
| 12/12/2006 | US7148321 Particularly relates to antibodies and fusion proteins in which a hinge region derives from one isotype and the CH2 domain derives from a different isotype |
| 12/12/2006 | US7148197 Orally administered small peptides synergize statin activity |
| 12/12/2006 | US7148030 For detection of caspases, trypsin and tryptase; comprises luciferase and amino-modified aminoluciferin or a carboxy-terminal protected derivative; solid phase synthesis |
| 12/07/2006 | WO2006130688A2 Compounds for inhibiting cathepsin activity |
| 12/07/2006 | WO2006130686A2 Hcv protease inhibitors in combination with food |
| 12/07/2006 | WO2006130553A2 Hcv protease inhibitors |
| 12/07/2006 | WO2006096515A3 Modified transferrin fusion proteins |
| 12/07/2006 | WO2006095234A3 Integrin targeted synthetic ligands for diagnostic and therapeutic applications |
| 12/07/2006 | WO2006092326A3 Mimetic peptides and the use thereof in the form of 20s, 26s and immunoproteasome inhibitors |
| 12/07/2006 | WO2006090289A3 Compounds for reducing aggregation of amyloid beta-peptide |
| 12/07/2006 | US20060276642 Compounds to treat Alzheimer's disease |
| 12/07/2006 | US20060276628 Pharmaceutical Formulations and Ligands for Use Therein; Mimetics for UEA-1 |
| 12/07/2006 | US20060276627 Angiotensin-converting enzyme inhibitory peptides |
| 12/07/2006 | US20060276622 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 12/07/2006 | US20060276621 Glycosylated specificity exchangers |
| 12/07/2006 | US20060276493 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication |
| 12/07/2006 | US20060276439 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| 12/07/2006 | US20060276408 Thrombin inhibitors; protease inhibition, kinase inhibition, CAAX inhibition, interference with peptides binding to SH2 domains and inhibition of MCH-I and/or MHC II presentation of peptides to T cell receptors |